Search

everythinglearnresearchcommunity

for

Search:↓

A patient with Cronkhite-Canada syndrome improved with nutritional support and steroids, but early diagnosis is key due to high mortality.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Antioxidants can help improve hair growth in people with alopecia areata.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.

Plant-based treatments can effectively and safely treat hair loss.

Dermatologists should customize cosmetic treatments for dark-skinned patients to minimize risks and complications.

Early intervention and patient education are crucial for managing alopecia areata.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Higher sebum levels are linked to more severe male baldness.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Hair cortisol may be a good indicator of recent mood in people with bipolar disorder.

A young Saudi girl with uncontrolled type 1 diabetes and hypothyroidism had two rare conditions, Mauriac syndrome and Van Wyk–Grumbach syndrome.

Lower LDL-c levels predict higher COVID-19 mortality.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Higher testosterone harms sperm motility, while higher estradiol improves sperm survival.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

Vitamin D is crucial for skin health and managing skin diseases.

Skin lesions in Carney complex are likely caused by a specific group of skin cells that promote pigment production due to a genetic mutation.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

The microbiome may be linked to hair loss and could be a target for new treatments.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.